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ABSTRACT   Matrix-producing carcinoma (MPC) of the breast is relatively rare. We report on 
a case of MPC of the breast during lactation. A female in her 30s noticed a lump in the upper 
inner and outer quadrants of her left breast 9 months into her pregnancy. She came hospital at 
one month after delivery. Ultrasonography revealed a hypoechoic tumor with an unclear border 
region. An MRI revealed a breast tumor approximately 19 mm in size, with dynamic studies 
demonstrating early contrast and ring enhancement. A core needle biopsy was performed, 
resulting in an histopathological diagnosis of invasive carcinoma ［Estrogen receptor-, 
Progesterone receptor-, Human epidermal growth factor receptor 2(HER2)-; stage I, T1cN0M0］. 
Breast-conserving surgery and a sentinel lymph node biopsy (SLNB) were performed. The SLNB 
was negative for cancer. Chemotherapy (FEC100, DTX75) and radiotherapy were performed as 
adjuvant therapies. Seventeen months after surgery, the patient is recurrence-free.
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〈Case Report〉
FOOTNOTES
   This report is secondary publication which was previously published in Rinsho Nyusen in Japanese1. Since many literatures 
referred in original Japanese article were written and published in Japanese, the selected reports described in English were mainly 
referred.
INTRODUCTION
   Matrix-producing carcinoma (MPC) of the 
mammary gland is a mix of the epithelial elements 
of carcinoma and a cartilaginous osseous stromal 
matrix１）. It is categorized as a Type 1 subtype of 
metaplastic cancer２，３）. This cancer is characterized 
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by the sudden transition of the tumor tissues to a 
mucosal matrix and/or cartilaginous osseous stromal 
matrix, with no transitional component, such as 
spindle cells or osteoclasts２－４）. It is a relatively 
rare tumor and its occurrence is reported to be less 
than 1% of all breast cancers５）. This case report and 
additional referential discussion is on our patient 
who had an MPC of the breast during lactation.
CASE REPORT
Patient
   A female in her early thirties.
Main complaint
   She recognized a tumor mass in her left breast 
during the 9th month of her pregnancy. The tumor 
mass was confirmed at her one month post-delivery 
checkup. She was soon after referred to Japan 
Community Healthcare Organization Kurume 
General Hospital for further examinations.
Previous medical history
   Nothing in particular. She had just delivered her 
second child and was breastfeeding at the time of 
the initial diagnosis.
Family medical history
   There was no history of breast or ovarian cancer in 
her biological family.
Initial Condition
   An approximately 2 cm sized tumor mass was 
palpable in the left upper inner and outer quadrants, 
which had a clear border with a smooth surface, and 
mobility was positive. No tumor was palpable in the 
axillary lymph node.
Blood biochemistry finding
   Tumor markers such as CEA and Ca15-3 were in 
the normal range (0.7 and 11.4 ng/ml, respectively). 
Other blood tests and biochemistry findings showed 
no abnormalities.
Mammography Finding
   The background parenchymal enhancement (BPE) 
showed a dense breast. An asymmetric density was 
found in the left U/0 area (Category 3) (Fig. 1).
Ultrasonographic finding
   Ultrasonography revealed a hypoechoic tumor 
mass of 16.5 x 19 mm with a clear border upper 
inner and outer quadrants of the left breast, partially 
Fig. 1.　Mammography (MLO, CC)
An asymmetric density was found in the left U/0 area.
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rough. The posterior echo showed irregularity and 
the anterior border was unclear.
   The tumor had a rich blood flow and the 
histological type was assessed as fibroadenoma and 
solid tubular carcinoma (Category 3b) (Fig. 2). The 
patient was lactating and the test images showed that 
fibroadenoma was the most likely. Thus, a cytology 
test was performed first, instead of a biopsy.
Breast MRI finding
   MRIs demonstrated a contrasted tumor mass in 
the left breast from the early phase, which was 
compatible with breast cancer. A T1-weighted image 
showed a high signal density around the tumor mass, 
rim enhanced, and a T2-weighted image showed an 
area with high to low internal density (Fig. 3).
Thoraco-abdominal contrast enhanced CT finding
   A tumor mass with contrast effect was found in 
the upper inner and outer quadrants of the left breast 
from the early phase. There were no enlarged lymph 
nodes that might signal a metastasis to the axillary 
lymph nodes. No other metastases were found.
Bone scintigraphic finding
   No bone metastasis was found.
Fine needle aspiration cytology finding
   Category: malignant. Increased nucleocytoplasmic 
ratio. Cells with increased chromatin in the 
nuclei found both sparsely and conglomerately in 
the necrotic background. Enlarged nucleus and 
Fig. 2.　Ultrasonographic finding
Ultrasonography revealed a hypoechoic tumor mass of 16.5 
x 19 mm with a clear border upper inner and outer quadrants 
of the left breast, partially rough. The posterior echo showed 
irregularity and the anterior border was unclear.
Fig. 3.　Breast MRI finding (T1W1, T2W1)
MRIs demonstrated a contrasted tumor mass in the left breast from the early phase. A T1-weighted image showed a high signal 
density around the tumor mass, rim enhanced, and a T2-weighted image showed an area with high to low internal density.
T1-weighted image T2-weighted image
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columnar cells were also found (Fig. 4). 
Core needle biopsy
   Category: malignant. Histological type: invasive 
breast ductal carcinoma. The cancer was triple-
negative; estrogen receptor-negative (ER Allred 
score: 0), progesterone receptor-negative (PgR 
allred score: 0), and human epidermal growth 
factor receptor 2(HER2) negative (0). The mitotic 
count had 40 in 10 views (mitotic index 4), and an 
invasion of high grade nuclear atypical tumor cells 
was identified (nuclear grade: 3, (nuclear atypia: 
3, mitotic count: 3)). The surrounding area of the 
carcinoma had a cellular territory with a matrix-like 
stroma.
   From all of the above, the patient was diagnosed 
with left breast cancer, T1cN0M0 stage I. Breast-
conserving surgery and a sentinel lymph node 
biopsy were performed. Axillary dissection was 
unnecessary due to the negative results for both 
touch smear cytology and one-step nucleic acid 
amplification for the sentinel lymph node.
Macroscopic finding
   The solid, white tumor was 15 mm x 14 mm. The 
inside had partial necrosis (Fig. 5).
Histopathological finding of the removed tumor
   An oval growth in the tumor was found to have 
lactating mammary glands in the background. The 
tumor component was located in the peripheral area 
and the tumor component had a matrix-producing 
and necrosis towards the center area (Fig. 6-1). 
Cancer cell growth of a relatively high grade nuclear 
atypia was found and lactating mammary glands 
in the background in the peripheral area (Fig. 6-2). 
Cartilaginous osseous stromal matrix-producing 
was found in the area surrounding the cancer cells, 
which resulted in a diagnosis of MPC, a rare form 
of metaplastic cancer (Fig. 6-3). Vessel invasion was 
not found. 
   Immuno-histochemistry tests were ER negative, 
PgR negative, and HER2 negative. Histopathological 
stump was also negative.
Fig. 4.　Fine needle aspiration cytology finding
Cells with increased chromatin in the nuclei found in the 
necrotic background. Enlarged nucleus and columnar cells 
were found.
Fig. 5.　Removed specimen
The solid, white tumor was 15 mm x 14 mm. The inside had 
partial necrosis.
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Therapeutic course
   For post-operative adjuvant therapy, four courses 
of FEC100 therapy (5-FU 500 mg/m2, Epirubicine 
100  mg/m2,  Cyclophosphamide 500  mg/m2), 
and four courses of DTX75 therapy (DTX 75 
mg/m2) were performed. Following chemotherapy, 
radiotherapy (50 Gy total) was performed on the 
residual breast. Seventeen months after surgery, the 
patient is recurrence-free.
DISCUSSION
   MPC was first reported by Wargotz et al. in 1989２）. 
MPC is characterized by an overductal carcinomatous 
component with a direct transition to parts with 
cartilaginous or osseous differentiation which lack 
an interspersed spindle cell component２，３）. The 
pathogenesis, progress, standardized treatment 
protocols and prognosis of MPC are limited because 
of a lack of large scale clinical studies. 
   There is a report of poor prognosis for MPC 
when compared with invasive ductal breast cancer 
Fig. 6.　
1  Histopathological finding of the removed tumor Magnified images
An oval growth in the tumor was found to have lactating mammary glands in the background. The tumor component was located 
in the peripheral area and the tumor component had a matrix-producing (carcinoma?) and necrosis towards the center area （shown 
with arrow ←）
2  H.E. Stain (high magnification view)
Cancer cell growth of a relatively high grade nuclear atypia in the peripheral area and the change of the mammary glands in the 
background.
3  H.E. Stain (medium magnification view)
Cartilaginous osseous stromal matrix-producing (carcinoma?) was found in the area surrounding the cancer cells.
1
2
3
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in general, and there is also a report of relatively 
preferable prognosis among metaplastic cancers６）. 
Under immuno-histopathological examination, 
MPC is usually triple negative３）, and the MPC in 
this case report was indeed a triple negative breast 
cancer (TNBC).
   A strong ring enhancement in the CTs and MRIs 
in many cases is one of the diagnostic imaging 
characteristics. This means that a greater portion 
of the epithelial carcinoma component exists in the 
tumor peripheral area and a larger cartilaginous 
osseous matrix component exists in the center７）. 
Therefore, angiogenesis that brings enhancement 
effectiveness seems to be distributed in the tumor 
peripheral area. A similar ring enhancement was 
found in this case as well. 
   It is also reported that ultrasonographic images 
of MPC often demonstrate a ring state７）. The 
tumor based matrix component and collagenous 
fibers intricately cross with each other and become 
a reflection source with a high echo８，９）. On the 
other hand, the tumor peripheral area where tumor 
cells are dense demonstrates a low echo. Thus, a 
ring can be observed. The matrix component of the 
patient in this case report was mixed with the tumor 
component and therefore didn’t show the typical 
ring state８，９）. However, after a more detailed 
examination of the patient’s ultrasonography, the 
tumor peripheral area showed a lower echoic image 
compared to the internal echo, and the cell density 
of the tumor mass was higher in the peripheral area. 
These findings were compatible with MPC.
   The occurrence of breast cancer during lactation 
is reported to be relatively rare at less than 3%10）. 
In recent years, there was a report indicating a 
relationship with the BRCA1 gene. Breast cancer 
during lactation is said to have no characteristic 
histological type, but often shows triple-negative. 
We could find no published reports about MPC of 
the breast during lactation. There are more than a 
few patients with breast cancer during lactation who 
go undiagnosed. Finding a cancer by palpation or 
mammography is difficult due to the development 
of mammary gland tissues during lactation, and 
there could also be separate mammary gland issues 
caused by breast feeding. Therefore, breast cancer 
is sometimes found in an advanced stage. Breast 
cancer during lactation has been recognized for 
its poor prognosis10）. However, a recent report has 
stated that if the disease is diagnosed at an early 
stage, the prognosis is as good as that of breast 
cancer for patients of a similar age11）. Lactating 
mammary glands during the perioperative period 
can be a concern, but with proper care, post-
operative inflammation and wound infection can 
be prevented. Patients at our facility take an anti-
prolactin and cool down the breasts to suppress the 
amount of breast milk production. 
   The number of late marriages and late childbirths 
is increasing, meaning that the number of breast 
cancers during pregnancy and the subsequent 
lactating period will also likely increase. Therefore, 
a larger variety of histological types will be expected 
in the future.
   Not only are there very few reported cases on 
MPC of the mammary glands, but there also 
aren’t any established treatments nor well described 
biological characteristics or prognoses. It is the 
same with breast cancer during lactation. No gene 
search has been done in this case on these specific 
condition, and more cases need to be collected to be 
examined in the future to study the relationship with 
juvenile breast cancer and BRCA mutation.
CONCLUSION
   MPC is a very rare metaplastic breast variant 
type and currently there aren’t sufficient findings 
or expertise about it. We could not locate any 
previously published literature on MPC of the breast 
during the lactating period and therefore are sharing 
our experience in this case report.
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